ATR and neoplasm: This finding raised the exciting possibility that ATR inhibitors monotherapy could potentiate the cytotoxic effects of radiation while enhancing CD8+ T cell-dependent anti-tumor activity following radiation, resulting in a durable anti-tumor immune response [159].